title: Fat-1 transgenic mice with elevated omega-3 fatty acids are protected from allergic airway responses.
abstract: Omega-3 polyunsaturated fatty acids (n-3 PUFA) have been implicated in the alleviation of asthma. Recent studies have demonstrated that the n-3 PUFA derived lipid mediators, protectin D1 and resolvin E1, may act as potent resolution agonists in airway inflammation. The effects of the n-3 PUFA tissue status itself on asthma pathogenesis remains to be further investigated. In this study allergic airway inflammation induced by allergen sensitization and aerosol challenge in Fat-1 and wild-type mice was investigated. Fat-1 transgenic mice displayed increased endogenous lung n-3 PUFA. When allergen-sensitized and aerosol-challenged, these animals had decreased airway inflammation with decreased leukocyte accumulation in bronchoalveolar lavage fluid and lung parenchyma. The Fat-1 mice had a shift to the right in the dose-response relationship for methacholine induced bronchoconstriction with a significant increase in the log ED200. The Fat-1 mice had lower BALF concentrations of the pro-inflammatory cytokines IL-1α, IL-2, IL-5, IL-9, IL-13, G-CSF, KC and RANTES. Furthermore, increased lung tissue amounts of the counter-regulatory mediators protectin D1 and resolvin E1 were found in Fat-1 mice after bronchoprovocative challenge. These results therefore demonstrate a direct protective role for lung n-3 PUFA in allergic airway responses and an increased generation of protectin D1 and resolvin E1 in this context.
authors: Laboratory for Lipid Medicine and Technology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02114, USA.
authors: Sueleyman
authors: S
authors: Bilal
authors: Oliver
authors: O
authors: Haworth
authors: Lijun
authors: L
authors: Wu
authors: Karsten H
authors: KH
authors: Weylandt
authors: Bruce D
authors: BD
authors: Levy
authors: Jing X
authors: JX
authors: Kang
references: J Exp Med. 2005 Mar 7;201(5):713-22
references: 15753205
references: Biomed Pharmacother. 2006 Nov;60(9):502-7
references: 17045449
references: Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13175-80
references: 9371819
references: Annu Rev Immunol. 2006;24:147-74
references: 16551246
references: Curr Med Chem. 2006;13(19):2291-8
references: 16918355
references: J Immunol. 2005 Apr 1;174(7):4345-55
references: 15778399
references: N Engl J Med. 2001 Feb 1;344(5):350-62
references: 11172168
references: Am J Respir Crit Care Med. 2005 Oct 1;172(7):824-30
references: 15961693
references: Nat Immunol. 2008 Aug;9(8):873-9
references: 18568027
references: Nature. 2004 Feb 5;427(6974):504
references: 14765186
references: J Immunol. 2007 Jan 1;178(1):496-502
references: 17182589
references: Proc Natl Acad Sci U S A. 2006 Jul 25;103(30):11276-81
references: 16847262
references: J Exp Med. 1986 May 1;163(5):1085-99
references: 3486243
references: Am J Respir Crit Care Med. 2009 Mar 15;179(6):474-83
references: 19136374
references: Br J Pharmacol. 2008 Mar;153 Suppl 1:S200-15
references: 17965751
references: N Engl J Med. 2004 Feb 5;350(6):560-9
references: 14762183
references: Eur Respir J. 1994 Oct;7(10):1821-4
references: 7828691
references: BMC Biochem. 2005 Mar 24;6:5
references: 15790399
references: BMC Complement Altern Med. 2006 Jul 19;6:26
references: 16854238
references: J Immunol. 2003 Mar 15;170(6):3296-305
references: 12626589
references: Int Arch Allergy Immunol. 2006;140 Suppl 1:55-8
references: 16772728
references: Nature. 1999 Nov 25;402(6760 Suppl):B2-4
references: 10586888
references: Int Arch Allergy Immunol. 2000 Dec;123(4):327-32
references: 11146390
references: Acta Med Scand. 1980;208(5):401-6
references: 7457208
references: Biochim Biophys Acta. 2008 Nov;1782(11):634-41
references: 18832028
references: Nature. 2007 Jun 14;447(7146):869-74
references: 17568749
references: Annu Rev Pathol. 2008;3:279-312
references: 18233953
references: Hepatology. 2007 Apr;45(4):864-9
references: 17393517